SGLT2 inhibition and cardiovascular outcomes: lessons from recent clinical trials.
21 May 2016 (13:05 - 13:25)
Organised by:
About the speaker

St. Michael's Hospital, Toronto (Canada)
4 More presentations in this session



Professor N. Sattar (Glasgow, GB)
Professor S. Anker (Berlin, DE)
Professor A. Voors (Groningen, NL)
Doctor D. Fitchett (Toronto, CA)
Professor N. Sattar (Glasgow, GB)
Access the full session
The Event
HEART FAILURE 2016
21 May 2016
13:05 CET
You may be interested in
Congress Session
Congress Session
Congress Session




